Tofacitinib in Stricturing Colonic Crohn's Disease.

IF 0.5 Q4 GASTROENTEROLOGY & HEPATOLOGY

ACG Case Reports Journal Pub Date : 2025-05-02 eCollection Date: 2025-05-01 DOI:10.14309/crj.0000000000001692

Simone Chin, Matthew Choy, Peter De Cruz

引用次数: 0

Abstract

Tofacitinib has described efficacy in ulcerative colitis but not Crohn's disease (CD). However, patients with stricturing CD were excluded from initial randomized controlled trials. We report a case of stricturing colonic CD, which responded to tofacitinib therapy.

查看原文本刊更多论文

托法替尼治疗狭窄性结肠克罗恩病

托法替尼对溃疡性结肠炎有疗效，但对克罗恩病（CD）无效。然而，患有狭窄性乳糜泻的患者被排除在初始随机对照试验之外。我们报告一例狭窄性结肠CD，对托法替尼治疗有反应。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACG Case Reports Journal GASTROENTEROLOGY & HEPATOLOGY-

自引率

14.30%

发文量

170

审稿时长

12 weeks

期刊介绍： ACG Case Reports Journal is a peer-reviewed, open-access publication that provides GI and hepatology fellows, private practice clinicians, and other healthcare providers an opportunity to share interesting case reports with their peers and with leaders in the field. ACG Case Reports Journal publishes case reports, images, videos and letters to the editor in all topics of gastroenterology and hepatology, including: Biliary Colon Endoscopy Esophagus Functional Bowel Disorders Inflammatory Bowel Disease Liver Nutrition and Obesity Pancreas Pathology Pediatric Small Bowel Stomach.